Genetic tests unlikely to help improve drug treatment for depression, according to new cohort study

There has been a lot of discussion over recent years about the ways in which genetic testing may help make the treatment of depression become more targeted and effective. The theory is that genetic markers may help predict how different people are likely to respond to different drugs. This is clearly something that would interest patients and clinicians, as currently less than 50% of people with depression see their symptoms improving when they take their first antidepressant. The study was carried out by a consortium of people from academia and industry. Many drug companies were involved in the research and the sources of funding and competing interests are clearly set out in the full-text of the article.

View the original article here: Genetic tests unlikely to help improve drug treatment for depression …

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend